QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

PHG

QT69Koninklijke Philips N.V.
NYSE·Healthcare·Medical - Devices·NL
Latest market price
26.78
+0.54+2.06%
OverviewShort InterestFilings
PHGQT69Koninklijke Philips N.V.·NYSE
OverviewShort InterestFilings
26.78+2.06%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E22.39EPS (ttm)1.17
Insider Own-
Shs Outstand982.89M
Perf Week2.57%
Market Cap25.43BForward P/E13.45EPS next Y1.99Insider Trans-Shs Float-Perf Month2.80%
Enterprise Value31.75BPEG0.16EPS next Q0.47Inst Own-Short Float-Perf Quarter-0.30%
Income1.14BP/S1.26EPS this Y53.01%Inst Trans-Short Ratio-Perf Half Y0.94%
Sales20.23BP/B1.91EPS next Y11.25%ROA3.56%Short Interest-Perf YTD-1.11%
Book/sh13.44P/C9.47EPS next 5Y9.24%ROE8.96%52W High33.44 -19.92%Perf Year21.12%
Cash/sh3.05P/FCF11.61EPS past 3/5Y-ROIC5.76%52W Low21.95 22.00%Perf 3Y-
Dividend Est.0.99 (3.70%)EV/EBITDA10.19Sales past 3/5Y2.38% 0.38%Gross Margin45.20%Volatility1.80% 1.75%Perf 5Y-
Dividend TTM0.99 (3.70%)EV/Sales1.57EPS Y/Y TTM315.67%Oper. Margin8.99%ATR (14)0.63Perf 10Y-
Dividend Ex-DateMay 13, 2026Quick Ratio0.90Sales Y/Y TTM4.89%Profit Margin5.50%RSI (14)53.28Recom2.59
Dividend Gr. 3/5Y0.11% 3.87%Current Ratio1.32EPS Q/Q0.00%SMA201.73%Beta1.03Target Price-
Payout33.81%Debt/Eq0.71Sales Q/Q6.08%SMA50-0.45%Rel Volume1.23Prev Close26.24
Employees67,247LT Debt/Eq0.63EarningsJul 28SMA200-4.31%Avg Volume1.22MPrice26.78
IPO DateMar 17, 1980Option/ShortYes / YesEPS/Sales Surpr.12.50% 2.20%Net Debt/EBITDA2.03Volume1,496,050Change2.06%
Analyst Ratings
DateActionAnalystRatingTarget
Feb-20-25UpgradeUBSNeutral → Buy
Oct-29-24UpgradeJefferiesUnderperform → Hold
May-13-24UpgradeBernsteinMarket Perform → Outperform
Apr-30-24UpgradeUBSSell → Neutral
Apr-30-24UpgradeJP MorganUnderweight → Neutral
Jul-25-22DowngradeSociete GeneraleBuy → Hold
Jan-20-22DowngradeJefferiesBuy → Hold
Jan-14-22UpgradeHSBCHold → Buy
Jan-12-22DowngradeCitigroupBuy → Neutral
Jul-08-21DowngradeDeutsche BankBuy → Hold
Latest News
Jun-11-26
Jun-11-2607:05AM
ResMed: GLP-1 Threats Are OverstatedSeekingAlpha
07:05AM
ResMed: GLP-1 Threats Are OverstatedSeekingAlpha
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue20,45120,11919,497
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A11,20911,02911,087
Gross Profit9,2439,0918,410
Selling, General and Administrative Excl. Other5,6865,6075,483
Research and Development1,8981,9181,890
Other Operating Expense-92-41464
Operating Income1,7501,606572
Interest Expense405375365
Unusual Expense
———
Non-Operating Income (Expense)-98-10275
Net Income Before Taxes1,4681,333133
Income Taxes3473181,042
Consolidated Net Income1,1241,010-759
Net Income From Continuing Operations1,1231,015-909
Net Income1,1241,010-759
EPS (Recurring)1.171.07-0.81
EPS (Basic, Before Extraordinaries)1.171.07-0.81
EPS (Diluted)1.171.05-0.81
EBITDA3,1392,9782,000
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio22.8925.81—
Price To Sales Ratio1.251.29—
Gross Margin45.2045.1943.13
Operating Margin8.567.982.93
Net Margin5.505.02-3.89
Shares Outstanding952962933
Market Capitalization25,49526,051—
Operating Lease Expense
———
Insider Trading Volume
$28.35$26.51$24.66$22.81$20.97● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR